Amrutanjan Health Care Limited

rs,

AMRUTANJAN Dear Sir / Madam, BSE Limited Department of Corporate Services 1* Floor, P.J. Towers, Dalal Street, Mumbai 400 001 Scrip Code: 590006 Sub: Investor Presentation for the quarter end

69.81%

16.29 12.06 51.17 8.66 6.43 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Growth: 69.81% Growth: 88.11% Growth: 87.56% Investor Presentation | Quarter Ended 30th June 2021 7 Expenses

88.11%

51.17 8.66 6.43 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Growth: 69.81% Growth: 88.11% Growth: 87.56% Investor Presentation | Quarter Ended 30th June 2021 7 Expenses – Q1 FY22 (Rs. i

87.56%

.43 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Q1 FY22 Q1 FY21 Growth: 69.81% Growth: 88.11% Growth: 87.56% Investor Presentation | Quarter Ended 30th June 2021 7 Expenses – Q1 FY22 (Rs. in Crores) Emplo

58.40%

1 FY22 – OTC Division (Rs. in Crores) Gross Sales - OTC 74.59 47.09 Q1 FY22 Q1 FY21 Growth: 58.40% Gross Sales - Comfy 11.17 8.63 Q1 FY22 Q1 FY21 Growth: 29.43% Notes: • Key raw material p

29.43%

9 Q1 FY22 Q1 FY21 Growth: 58.40% Gross Sales - Comfy 11.17 8.63 Q1 FY22 Q1 FY21 Growth: 29.43% Notes: • Key raw material prices including Menthol crystal price are lower when compared to Q1

264 basis point

he prices of packing material are higher when compared to Q1 FY21. • Gross Margin has improved by 264 basis points when compared to Q1 FY21. • Advertisement spend for Q1 FY22 is at Rs.4.28 cr against Rs.0.83 cr

Rs.4.28

improved by 264 basis points when compared to Q1 FY21. • Advertisement spend for Q1 FY22 is at Rs.4.28 cr against Rs.0.83 cr for Q1 FY21. Investor Presentation | Quarter Ended 30th June 2021 9 Financ

Rs.0.83

asis points when compared to Q1 FY21. • Advertisement spend for Q1 FY22 is at Rs.4.28 cr against Rs.0.83 cr for Q1 FY21. Investor Presentation | Quarter Ended 30th June 2021 9 Financials – Q1 FY22 – Be

202.01%

everage Division (Rs. in Crores) Gross Sales - Beverages 12.02 3.98 Q1 FY22 Q1 FY21 Growth: 202.01% Gross Sales - Electro Plus 8.96 2.10 Q1 FY22 Q1 FY21 Growth: 326.67% Notes: • Gross Margi

326.67%

FY22 Q1 FY21 Growth: 202.01% Gross Sales - Electro Plus 8.96 2.10 Q1 FY22 Q1 FY21 Growth: 326.67% Notes: • Gross Margin has improved by 1,540 basis points when compared to Q1 FY21 mainly due to

1,540 basis point

ectro Plus 8.96 2.10 Q1 FY22 Q1 FY21 Growth: 326.67% Notes: • Gross Margin has improved by 1,540 basis points when compared to Q1 FY21 mainly due to higher Electro plus volume. • Advertisement spend is at

Notes

2

We remain focused on executing our key priorities

1

Notes

• Key raw material prices including Menthol crystal price are lower when compared to Q1 FY21. • The prices of packing material are higher when compared to Q1 FY21. • Gross Margin has improved by 264 basis points when compared to Q1 FY21. • Advertisement spend for Q1 FY22 is at Rs.4.28 cr against Rs.0.83 cr for Q1 FY21. Investor Presentation | Quarter Ended 30th June 2021 9 Financials – Q1 FY22 – Beverage Division (Rs. in Crores) Gross Sales - Beverages 12.02 3.98 Q1 FY22 Q1 FY21 Growth: 202.01% Gross Sales - Electro Plus 8.96 2.10 Q1 FY22 Q1 FY21 Growth: 326.67%

Notes

• Gross Margin has improved by 1,540 basis points when compared to Q1 FY21 mainly due to higher Electro plus volume. • Advertisement spend is at 1.77 cr for Q1 FY22 against 0.42 cr for Q1 FY21. • Business is continuing to be healthier with complete cash collected for Fruitnik. Investor Presentation | Quarter Ended 30th June 2021 10 Way Forward Investor Presentation | Quarter Ended 30th June 2021 11 Way Forward

We remain focused on executing our key priorities

• Continue the growth rhythm of last year • Expand distribution • Go digital • Strengthen Beverage business • Costs control Investor Presentation | Quarter Ended 30th June 2021 12 Investor Presentation | Quarter Ended 30th June 2021 13